Concept · The Lens

Buy & hold vs exit strategies.

~7 min read · Backed by our own backtest

We spent months backtesting every "smart" exit strategy you can imagine — trailing stops, profit targets, time-based exits, regime-based exits, Sharpe-optimized exits, combinations of all of them. The data was unambiguous. Buy & hold beat every one of them. Not by a tiny margin. By a wide one. This article documents what we found, what we changed, and what the implication is for how a signal-based newsletter should actually be used.

The conventional wisdom — "let your winners run but cut your losers fast" — is one of those things that sounds like sophisticated risk management and turns out, on data, to be wealth-destroying for the typical case. The intuition is wrong because it ignores how much of a portfolio's return comes from a tiny minority of multi-baggers, and how often the smart-exit rules clip those exact positions out.

What we tested

We ran every published signal in our 87-thesis history through five different exit-management strategies, plus a custom "combined" row. The same entries, the same prices, the same data. Only the exit logic varied:

Buy & Hold
Winner
Buy on the signal, hold to thesis invalidation. No trailing stop, no profit target, no time exit. Sell only when the underlying thesis is broken by new data (insider selling reverses, regulatory rejection, balance sheet rupture).
Catastrophic Stop only
Close 2nd
Buy & hold, with one safety valve: exit if the position is down more than 70% from entry. The "the company actually died" stop, not a price-movement stop. Caught one or two complete blowups; cost us multi-bagger upside in zero cases.
Trailing Stop (typical)
Far behind
Buy, then exit if the price falls X% from its peak. Standard "let winners run" rule. Sounds great, but: most multi-baggers see 30–50% drawdowns mid-thesis before continuing up. Trailing stops exit at the drawdown bottom, just before the recovery.
Profit Target
Worst
Exit at a fixed +X% gain. Locks in small wins, caps the tail. Since portfolio returns are dominated by the rare 5–10x winners, capping them at +50% or +100% destroys most of the alpha. Mathematically guaranteed to underperform.
Stop + Re-entry
Negative
Exit on a stop, re-enter when the thesis re-confirms. Sounds clever, performs terribly: re-entries are almost always at higher prices than the exit, and the round-trip churn compounds slippage / taxes / spreads.
Pyramid Scale-Out
Mixed
Sell 25% at +50%, another 25% at +100%, etc. Reduces psychological pressure but mechanically the same as a partial profit target — caps the tail without eliminating it. Slightly better than the others, still well behind buy & hold.
The number

Across our 87-thesis backtest, ranked by entry conviction: HIGH-conviction signals returned +489% on buy & hold over their average ~4.8 year holding window. Medium-conviction signals returned +148%. The same signals run through any of the smart-exit rules above returned dramatically less — and the trailing-stop strategy, in particular, gave up the majority of the conviction-driven outperformance.

The buy-and-hold conviction edge survives every robustness check we ran. Smart exits don't.

Why this is true (the math)

Portfolio returns are convex: dominated by the right tail. Across any large basket of stock picks, the median outcome is roughly flat-to-slightly-positive, but a handful of multi-baggers (5×, 10×, 30×) drag the average up massively. Any exit rule that truncates the right tail — and almost all "smart exits" do — hurts portfolio CAGR disproportionately.

Consider: in a basket of 87 names, if 5 of them go up 10× and the rest are flat, your average return is roughly (5 × 900% + 82 × 0%) / 87 ≈ +52% per name. Cap each winner at +200% (a "respectable" profit target) and your 5 winners now contribute 5 × 200% / 87 ≈ +11% — you've cut the basket's return by 80%. That's the cost of a profit target on a convex distribution.

Trailing stops are even more insidious. Most great theses involve mid-trade drawdowns of 30%, 40%, sometimes 50%. NVDA had a ~70% drawdown in 2022 inside a multi-year megathesis. A 25% trailing stop would have exited NVDA at the 2022 bottom — and almost no one buys back into a name they just stopped out of, especially after a painful loss. So the trailing stop doesn't just give up the recovery; it psychologically prevents re-entry.

What this means for how you use the system

Several implications fall out of this finding:

The honest counter-argument

Some serious investors disagree with everything above. The most common counter:

"Buy & hold is fine for institutional money with a 10-year horizon. Retail investors need to manage drawdown risk because they don't have the emotional capacity to sit through a -50% paper loss without panic-selling at the worst moment."

This is a real point. The data says buy & hold is superior if you can actually hold. The historical record of retail behavior is that most people can't — they sell at the bottom of every drawdown and buy back near the top. If that's the realistic behavior, then a mechanical trailing stop might genuinely save them from worse outcomes than buy & hold would.

Our view: the answer isn't a worse-but-survivable exit rule. The answer is position sizing that lets you sit through drawdowns without panic. If you're sized correctly — meaning no single position can blow up your portfolio — a 50% drawdown on one name is uncomfortable but not catastrophic, and you can wait it out. If you're sized aggressively, the drawdowns force you out at exactly the wrong time, regardless of what the data says.

Bottom line: the cleverness budget in investing is finite. We've concluded ours is best spent on the entry side — convergent-catalyst selection, conviction scoring, watching for thesis invalidation. Exits we keep simple: buy, hold, sell only when the thesis breaks or the catastrophic stop trips.